Related Experiment Video
Updated: Jan 21, 2026

13:04
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
9.3K
Current Research Progress on Long Noncoding RNAs Associated with Hepatocellular Carcinoma
Haihong Shi1, Yuxin Xu2, Xin Yi1
1Department of Biochemistry and Molecular Biology, Jiamusi University School of Basic Medicine, Jiamusi, Heilongjiang 154007, China.
Analytical Cellular Pathology (Amsterdam)
|July 26, 2019
Summary
Long noncoding RNAs (lncRNAs) play roles in liver cancer development and progression. This review explores lncRNA functions and their potential as therapeutic targets for hepatocellular carcinoma (HCC).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a major cause of cancer-related death worldwide.
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their involvement in human cancers, including liver cancer.
- Both oncogenic and tumor-suppressive lncRNAs are implicated in the complex biological processes of liver cancer.
Purpose of the Study:
- To review the regulatory mechanisms and functional roles of lncRNAs in hepatocellular carcinoma.
- To evaluate the potential of lncRNAs as novel therapeutic targets for HCC treatment.
Main Methods:
- Literature review of studies on lncRNA regulation and function in liver cancer.
- Analysis of pathological and biological activities influenced by lncRNAs, such as cell proliferation, apoptosis, invasion, and metastasis.
Main Results:
- lncRNAs are involved in critical cellular processes relevant to liver cancer.
- Specific lncRNAs can act as either oncogenes or tumor suppressors in HCC.
- Dysregulation of lncRNAs contributes to cancer progression, including invasion and metastasis.
Conclusions:
- lncRNAs are key players in the pathogenesis of hepatocellular carcinoma.
- Understanding lncRNA regulation and function is crucial for developing new diagnostic and therapeutic strategies for HCC.
- lncRNAs represent a promising avenue for future liver cancer research and targeted therapies.
Related Concept Videos
siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
piRNA - Piwi-interacting RNAs
7.5K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.5K
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
lncRNA - Long Non-coding RNAs
3.5K
3.5K
Small interfering RNAs (siRNA)
4.3K
4.3K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K

